# Pruritic rash secondary to cendakimab, an investigative IL-13 inhibitor

**Authors:** Darartu M. Gamada, Jennifer Crimmins, David A. Leiman, Melodi Javid Whitley

PMC · DOI: 10.1016/j.jdcr.2025.11.029 · 2025-11-29

## Full-text entities

- **Genes:** IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}
- **Diseases:** Pruritic rash (MESH:D005076)
- **Chemicals:** cendakimab (MESH:C000625155)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12804603/full.md

---
Source: https://tomesphere.com/paper/PMC12804603